title: Eosinophils derived from acute promyelocytic leukemia cells after arsenic trioxide treatment.
authors.forename: Kazuhito
authors.initials: K
authors.lastname: Yamamoto
authors.forename: Nobuhiko
authors.initials: N
authors.lastname: Emi
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Kajiguchi
authors.forename: Shunji
authors.initials: S
authors.lastname: Yamamori
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Ono
authors.forename: Tomoki
authors.initials: T
authors.lastname: Naoe
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage*; D002454:Cell Differentiation / Q000187:drug effects; D019070:Cell Lineage / Q000187:drug effects; D004804:Eosinophils / Q000473:pathology*; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000473:pathology*; D008875:Middle Aged; D010087:Oxides / Q000008:administration & dosage*
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide